
|Articles|February 11, 2008
FDA's crackdown on bio-identical hormones sparks controversy
Pharmacists are up in arms over the warning FDA has issued to seven compounding pharmacies about bioidentical hormone replacement therapy.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Chronic Corticosteroid Use Harms Health, Increases Cost for Patients With Asthma
2
Evolving Regulatory Criteria Fuel Rx-to-OTC Rejections
3
Vitamin D Shows Potential in Managing Metabolic Health for Diabetes
4
CMS Announces 15 New High-Cost Drugs for Medicare Price Negotiation Program
5






















